Literature DB >> 19840553

Immune activation in brain aging and neurodegeneration: too much or too little?

Kurt M Lucin1, Tony Wyss-Coray.   

Abstract

Until recently, the brain was studied almost exclusively by neuroscientists and the immune system by immunologists, fuelling the notion that these systems represented two isolated entities. However, as more data suggest an important role of the immune system in regulating the progression of brain aging and neurodegenerative disease, it has become clear that the crosstalk between these systems can no longer be ignored and a new interdisciplinary approach is necessary. A central question that emerges is whether immune and inflammatory pathways become hyperactivated with age and promote degeneration or whether insufficient immune responses, which fail to cope with age-related stress, may contribute to disease. We try to explore here the consequences of gain versus loss of function with an emphasis on microglia as sensors and effectors of immune function in the brain, and we discuss the potential role of the peripheral environment in neurodegenerative diseases.

Entities:  

Mesh:

Year:  2009        PMID: 19840553      PMCID: PMC2834890          DOI: 10.1016/j.neuron.2009.08.039

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  163 in total

Review 1.  Complement and innate immunity.

Authors:  W C Song; M R Sarrias; J D Lambris
Journal:  Immunopharmacology       Date:  2000-08

2.  Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses.

Authors:  Seung-Yong Seong; Polly Matzinger
Journal:  Nat Rev Immunol       Date:  2004-06       Impact factor: 53.106

3.  Acetylcholinesterase inhibitors effects on oncostatin-M, interleukin-1 beta and interleukin-6 release from lymphocytes of Alzheimer's disease patients.

Authors:  Marcella Reale; Carla Iarlori; Francesco Gambi; Isabella Lucci; Mirella Salvatore; Domenico Gambi
Journal:  Exp Gerontol       Date:  2005-01-08       Impact factor: 4.032

4.  Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.

Authors:  K Ohashi; V Burkart; S Flohé; H Kolb
Journal:  J Immunol       Date:  2000-01-15       Impact factor: 5.422

5.  Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

Authors:  S T Smiley; J A King; W W Hancock
Journal:  J Immunol       Date:  2001-09-01       Impact factor: 5.422

6.  Downregulation of macrophage inhibitory molecules in multiple sclerosis lesions.

Authors:  Nathalie Koning; Lars Bö; Robert M Hoek; Inge Huitinga
Journal:  Ann Neurol       Date:  2007-11       Impact factor: 10.422

7.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

8.  Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease.

Authors:  Manuel Rodriguez; Lydia Alvarez-Erviti; Francisco J Blesa; Maria C Rodríguez-Oroz; Ainhoa Arina; Ignacio Melero; Luís Isaac Ramos; Jose A Obeso
Journal:  Neurobiol Dis       Date:  2007-08-07       Impact factor: 5.996

Review 9.  Microglial degeneration in the aging brain--bad news for neurons?

Authors:  Wolfgang J Streit; Kelly R Miller; Kryslaine O Lopes; Emalick Njie
Journal:  Front Biosci       Date:  2008-05-01

10.  Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin.

Authors:  Milan Fiala; Philip T Liu; Araceli Espinosa-Jeffrey; Mark J Rosenthal; George Bernard; John M Ringman; James Sayre; Laura Zhang; Justin Zaghi; Sheila Dejbakhsh; Ben Chiang; James Hui; Michelle Mahanian; Anita Baghaee; Pamela Hong; John Cashman
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-24       Impact factor: 11.205

View more
  317 in total

1.  Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells.

Authors:  Stacey Cromer Berman; Chulani Galpoththawela; Assaf A Gilad; Jeff W M Bulte; Piotr Walczak
Journal:  Magn Reson Med       Date:  2010-10-06       Impact factor: 4.668

2.  Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission.

Authors:  Olivier Pascual; Sarrah Ben Achour; Philippe Rostaing; Antoine Triller; Alain Bessis
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-13       Impact factor: 11.205

3.  Neuroinflammation and cognitive dysfunction in chronic disease and aging.

Authors:  Amy M Hein; M Kerry O'Banion
Journal:  J Neuroimmune Pharmacol       Date:  2012-01-18       Impact factor: 4.147

4.  The impact of glial activation in the aging brain.

Authors:  Aileen M Lynch; Kevin J Murphy; Brian F Deighan; Julie-Ann O'Reilly; Yuri K Gun'ko; Thelma R Cowley; Rodrigo E Gonzalez-Reyes; Marina A Lynch
Journal:  Aging Dis       Date:  2010-09-04       Impact factor: 6.745

Review 5.  Systemic inflammatory cells fight off neurodegenerative disease.

Authors:  Michal Schwartz; Ravid Shechter
Journal:  Nat Rev Neurol       Date:  2010-06-08       Impact factor: 42.937

Review 6.  Effects of neuroinflammation on the regenerative capacity of brain stem cells.

Authors:  Isabella Russo; Sergio Barlati; Francesca Bosetti
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

7.  Dendritic degeneration, neurovascular defects, and inflammation precede neuronal loss in a mouse model for tau-mediated neurodegeneration.

Authors:  Tomasz Jaworski; Benoit Lechat; David Demedts; Lies Gielis; Herman Devijver; Peter Borghgraef; Hans Duimel; Fons Verheyen; Sebastian Kügler; Fred Van Leuven
Journal:  Am J Pathol       Date:  2011-08-10       Impact factor: 4.307

Review 8.  Review: microglia of the aged brain: primed to be activated and resistant to regulation.

Authors:  D M Norden; J P Godbout
Journal:  Neuropathol Appl Neurobiol       Date:  2013-02       Impact factor: 8.090

9.  FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Pharmacogenomics       Date:  2015       Impact factor: 2.533

Review 10.  Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disorders.

Authors:  Vijay K Ramanan; Andrew J Saykin
Journal:  Am J Neurodegener Dis       Date:  2013-09-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.